Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients
Open Access
- 7 October 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 24 (3) , 919-925
Abstract
Background. Inflammation in an ESRD patient may impact responsiveness to erythropoiesis-stimulating agent (ESA) therapy. We sought to investigate the association between C-reactive protein (CRP) levels and average per-administration epoetin alfa (EPO) dose over 3 months following a CRP measurement. Methods. The study is a retrospective cohort study of hemodialysis patients ≥18 years of age receiving care at a Fresenius Medical Care-North America facility between 1 July 2000 and 30 June 2002 who had no history of peritoneal dialysis. All patients had ≥1 CRP measurement and ≥3 months of recorded information before the CRP measurement (entry period). We evaluated the association between CRP levels and average hemoglobin (Hb) and per-administration EPO dose over the 3 months following the CRP measurement. Results. We identified 1754 patients with a CRP measurement; mean age was 62.6 years (SD 14.1), 51.5% were male, 56.2% were white and the median CRP value was 2.04 mg/dL (20.4 mg/L). Patients in the upper CRP quartiles were more likely to be older, recently hospitalized; have a catheter vascular access; have lower albumin, Hb and transferrin saturation levels and greater EPO doses. In the subsequent 3 months, EPO doses but not Hb levels were significantly higher for patients in the highest CRP quartile [3.21 mg/dL (32.1 mg/L)] ( P = 0.01). Conclusions. Inflammation as measured by an elevated CRP level appears to be an independent predictor of greater ESA dose requirements. Patients with the highest CRP levels required significantly higher ESA doses to achieve comparable Hb levels even after controlling for potential confounding variables.Keywords
This publication has 29 references indexed in Scilit:
- Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturationKidney International, 2007
- Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patientsNephrology Dialysis Transplantation, 2007
- Hemoglobin Level VariabilityClinical Journal of the American Society of Nephrology, 2006
- Serum Albumin, C-Reactive Protein, Interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and Mortality in Patients With ESRDAmerican Journal of Kidney Diseases, 2006
- C-reactive Protein Is a Strong Predictor of Mortality in Hemodialysis PatientsRenal Failure, 2006
- Is Hepcidin a Link between Anemia, Inflammation and Liver Function in Hemodialyzed Patients?American Journal of Nephrology, 2005
- Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its InternalizationScience, 2004
- Red blood cell physiology in critical illnessCritical Care Medicine, 2003
- Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patientsKidney International, 2002
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999